tiprankstipranks
Advertisement
Advertisement

LEXX Stock Latest News

Lexaria Bioscience announces ethics approval for Human Pilot Study 7
The FlyLexaria Bioscience announces ethics approval for Human Pilot Study 7
3d ago
NVO
LEXX
Lexaria Bioscience provides update on Human Pilot Study #7
PremiumThe Fly
Lexaria Bioscience provides update on Human Pilot Study #7
17d ago
NVO
LEXX
Lexaria Bioscience extends material transfer agreement with pharma company
PremiumThe Fly
Lexaria Bioscience extends material transfer agreement with pharma company
23d ago
LEXX
Lexaria Bioscience launches new study to examine next-gen GLP-1 drugs
PremiumThe Fly
Lexaria Bioscience launches new study to examine next-gen GLP-1 drugs
29d ago
LEXX
Lexaria Bioscience provides update on GLP-1 oral pill market
PremiumThe Fly
Lexaria Bioscience provides update on GLP-1 oral pill market
1M ago
LEXX
Lexaria Launches New GLP-1 Study to Expand Drug Delivery IP
PremiumCompany AnnouncementsLexaria Launches New GLP-1 Study to Expand Drug Delivery IP
1M ago
LEXX
Lexaria Bioscience engages CRO for 2026 GLP-1-A26-1 study
Premium
The Fly
Lexaria Bioscience engages CRO for 2026 GLP-1-A26-1 study
1M ago
LEXX
Lexaria Eyes Growing Oral GLP-1 Market After Eli Lilly’s Foundayo Approval
Premium
Company Announcements
Lexaria Eyes Growing Oral GLP-1 Market After Eli Lilly’s Foundayo Approval
1M ago
LEXX
Lexaria Bioscience ‘applauds’ Eli Lilly’s Foundayo drug approval
PremiumThe Fly
Lexaria Bioscience ‘applauds’ Eli Lilly’s Foundayo drug approval
1M ago
LLY
LEXX
Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform
PremiumCompany Announcements
Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform
2M ago
LEXX
Lexaria Bioscience to begin new human clinical study in GLP-1
PremiumThe Fly
Lexaria Bioscience to begin new human clinical study in GLP-1
2M ago
LEXX
Lexaria Bolsters Global Patent Portfolio With New GLP-1 and Cardiometabolic IP
PremiumCompany Announcements
Lexaria Bolsters Global Patent Portfolio With New GLP-1 and Cardiometabolic IP
2M ago
LEXX
Lexaria receives five new patents, including two for diabetes treatment
PremiumThe FlyLexaria receives five new patents, including two for diabetes treatment
2M ago
LEXX
Lexaria Targets Booming GLP-1 Market With Enhanced Oral Drug Platform
Premium
Company Announcements
Lexaria Targets Booming GLP-1 Market With Enhanced Oral Drug Platform
2M ago
LEXX
Lexaria Launches 2026 R&D Push to Advance GLP-1 and Cannabidiol Drug Delivery
Premium
Company Announcements
Lexaria Launches 2026 R&D Push to Advance GLP-1 and Cannabidiol Drug Delivery
3M ago
LEXX
Lexaria Bioscience announces 2026 R&D plans
PremiumThe Fly
Lexaria Bioscience announces 2026 R&D plans
3M ago
LEXX
Lexaria’s Oral Liraglutide Shows Comparable Performance and Fewer Side Effects in Human Study
PremiumCompany Announcements
Lexaria’s Oral Liraglutide Shows Comparable Performance and Fewer Side Effects in Human Study
4M ago
LEXX
Lexaria announces final results from GLP-1-H25-5 study
PremiumThe Fly
Lexaria announces final results from GLP-1-H25-5 study
4M ago
LEXX
Lexaria Bioscience Shareholders Endorse Directors and Auditors
PremiumCompany Announcements
Lexaria Bioscience Shareholders Endorse Directors and Auditors
4M ago
8K
LEXX
Lexaria Adds Six Global Patents, Reaches 60 Granted as It Rallies Shareholders Ahead of 2026 Meeting
PremiumCompany AnnouncementsLexaria Adds Six Global Patents, Reaches 60 Granted as It Rallies Shareholders Ahead of 2026 Meeting
4M ago
LEXX
Lexaria Bioscience awarded six additional patents
Premium
The Fly
Lexaria Bioscience awarded six additional patents
4M ago
LEXX
Lexaria Deepens GLP-1 Focus With DehydraTECH Advances, Patents and Fresh Capital
Premium
Company Announcements
Lexaria Deepens GLP-1 Focus With DehydraTECH Advances, Patents and Fresh Capital
4M ago
LEXX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >